BeStock  
Markets › Compare › CLYM vs FDMT

CLYM vs FDMT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CLYM · Climb Bio$9.19 ▼ 0.97%
FDMT · 4D Molecular Therapeutics$10.23 ▼ 4.57%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

92745408051070Nov 24, '25May 26, '26Nov 20, '26
  • CLYM +422.2%
  • FDMT -6.1%

Head to head

MetricCLYMFDMT
Price$9.19$10.23
Change today▼ 0.97%▼ 4.57%
Market cap$539.80M$576.76M
Return, 3 months-44.0%-33.5%
Return, year to date+129.8%+36.4%
Return, 1 year+440.6%-5.6%
P/E (TTM)––
P/B2.41.7
P/E percentile vs own 5y25th42nd
Dividend yield––
Revenue growth (YoY, latest qtr)–+4,505.6%
Net profit growth (YoY)-13.1%-37.2%
Gross margin––
Operating margin–-226.0%
Net margin–-208.6%
Return on equity-29.3%-56.7%
Analyst target vs. price+217.5%+183.5%
Analyst buy share100%86%
RSI (14)4137
30-day volatility102.8%85.0%
Max drawdown, 1 year-50.6%-39.0%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • FDMT is the largest of the group by market value.
  • CLYM has returned the most over the past year.
  • FDMT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top